Viewing Study NCT01011335

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:42 PM
Ignite Modification Date: 2026-03-04 @ 12:33 AM
Study NCT ID: NCT01011335
Status: COMPLETED
Last Update Posted: 2023-03-07
First Post: 2009-11-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Staphylococcus Aureus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Staphylococcus aureus View
None Skin and soft tissue infection View
None Methicillin-resistant Staphylococcus aureus View
None Recombinant alpha-toxoid (rAT) View
None Recombinant LukS subunit of Panton-Valentine Leukocidin (rLukS-PV) View